REDWOOD CITY, California, September 2 /PRNewswire/ --

Ingenuity Systems, the leading provider of information solutions for life
science researchers, today announced a multi-year agreement with
Bristol-Myers Squibb Company (NYSE: BMY) for use of the Ingenuity Pathways
Analysis (IPA) software application. Bristol-Myers Squibb will continue to
leverage IPA for the interpretation, modeling, and visualization of genomics
and proteomics data to identify key biological insights to accelerate their
drug discovery programs.

The agreement provides enterprise-wide access to IPA for Bristol-Myers
Squibb research scientists. Research teams have access to the newest version
of IPA, which supports Affymetrix GeneChip(R) Exon Arrays, supports many new
species, and includes recent enhancements such as the Path Designer
publishing tool and capabilities for metabolomics, biomarker, and toxicology
research. The all-in-one nature of IPA ensures easy workflows for maximum
efficiency across Bristol-Meyers Squibb's global organization.

"We are very pleased that Bristol-Myers Squibb has chosen Ingenuity as a
partner for its drug discovery and development programs," commented Sean
Scott, SVP Commercial Operations, Ingenuity Systems. "Bristol-Myers Squibb
has been a highly valued customer since 2004 and we regard their license
renewal and multi-year commitment as confirmation that IPA is an integral
part of their discovery programs."

About Ingenuity Pathways Analysis

Ingenuity Pathways Analysis is an all-in-one software application that
enables researchers to model, analyze, and understand the complex biological
and chemical systems at the core of life science research. IPA's search
capabilities provide users with access to the highest quality detail-rich
knowledge available on genes, drugs, chemicals, protein families, cellular
and disease processes, and signaling and metabolic pathways. IPA supports
analysis of data from all experimental platforms, and is used at all stages
of the drug discovery and development process, including target
identification and validation, biomarker discovery, molecular toxicology,
metabolomics, and pharmacogenomics. IPA has been broadly adopted and cited in
hundreds of peer-reviewed journals.

About Ingenuity Systems(R)

Ingenuity Systems is a leading provider of information solutions and
custom services for life science researchers, computational biologists and
bioinformaticists, and life science industry suppliers. Our long-term focus
on innovation in semantic search has allowed us to create groundbreaking
technologies that have one common goal -- to generate maximum value from all
types of biological and chemical knowledge. Ingenuity offerings leverage the
Ingenuity Knowledge Base, which contains uniquely structured literature
findings that allow scientists to ask complex biological questions and gain
rapid insight into their experimental data or systems of interest. Today,
Ingenuity's solutions are used by thousands of researchers at hundreds of
leading pharmaceutical, biotechnology, academic, and government research
institutions worldwide. http://www.ingenuity.com

Web site: http://www.ingenuity.com